Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Middlesex Water Files for Rate Request
-
How a Few Days in Nature Can Be Life-Changing for Teens
-
SB Financial Group Joins Russell 3000 Index
-
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
-
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
-
NodeOps Network $NODE Token Generation Event Sells Out in Minutes via Binance Wallet, Debuts Across Top Global Exchanges
-
WASTE CONNECTIONS ANNOUNCES DATES FOR SECOND QUARTER 2025 EARNINGS RELEASE
-
Halozyme Therapeutics Added to Russell 1000® Index
-
APPLICATIONS OPEN FOR NEXT TEN N-SISS: FELLOWS
-
Boeing Announces Chief Financial Officer Transition Plan
-
Ultra Clean Announces Retirement of Bill Bentinck, President of Services Division
-
Cisco & Wells Fargo to Host Silicon One Tech Talk
-
Fannie Mae Releases May 2025 Monthly Summary
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Industry First -- Supermicro Systems Certified by Intel for an Immersion Cooling Solution
-
Olin and K2 Announce Strategic Expansion of Bleach Distribution Partnership in California and the Western United States
-
Ameresco to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
FrontView REIT Appoints Pierre Revol, Seasoned Industry Executive, as Chief Financial Officer
-
RGP Announces Board Refreshment
-
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist
-
BGC Group Updates its Outlook for the Second Quarter of 2025
-
LogProstyle Inc. Announces Results of the 2025 Annual General Meeting of Shareholders
-
SkyWater Completes Acquisition of Fab 25, Expanding U.S. Pure-Play Foundry Capacity for Critical Semiconductor Technologies
-
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
-
Agree Realty Announces Second Quarter 2025 Earnings Release Date and Conference Call Information
-
Lumen Technologies Advances Financial Strategy to Support AI-Era Infrastructure Growth
-
Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025
-
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
-
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
-
Yorkville Acquisition Corp. Announces Closing of $172,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
-
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology
-
Zeo Energy Corp. Joins Russell Microcap® Index
-
Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
-
Results of Operations for the Three Months Ended March 31, 2025 - American Overseas Group Limited Announces Net Income Of $4.3 Million For the Three Months Ended March 31, 2025.
-
Ascent Industries Co. Completes Sale of American Stainless Tubing, Finalizing Transformation to Pure-Play Specialty Chemicals Platform
-
Enphase Energy Board of Directors Affirms Re-election of Thurman John Rodgers as Director of the Board
-
Top California Lender Welcomes New Investors to Fuel Expanded Lending Capacity
-
Nektar Therapeutics Announces Proposed Public Offering
-
Verastem Oncology Announces Nature Medicine Publication of the Results from the First-in-Human Phase 1 FRAME Study of Avutometinib in Combination with Defactinib in Solid Tumors, including Low-Grade S
-
SATO Technologies Corp. Provides Results From Shareholder Meeting
-
SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BRMK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Broadmark Realty Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
DMRC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BITF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitfarms Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
